紫杉醇联合顺铂同期放疗治疗局部区域性食管癌的临床分析被引量：3

下载PDF

导出

摘要目的研究分析紫杉醇联合顺铂同期放疗治疗局部区域性食管癌的临床效果。方法选取我院在2010年7月至2013年6月收治的78例局部区域性食管癌患者的临床资料进行研究分析,并随机将其分为治疗组(39例)和对照组(39例),对照组患者采用紫杉醇进行治疗,治疗组患者采用紫杉醇联合顺铂进行治疗,对比两组患者治疗效果。结果对比两组患者临床治疗效果,治疗组患者临床治疗总有效率(87.18%)显著优于对照组患者的(69.23%),有统计学意义(P<0.05)。结论紫杉醇联合顺铂同期放疗在治疗局部区域性食管癌疾病临床上效果显著,可有效提高患者生存率。

作者葛曦刘勇郑杰刘华童薇马志宇

机构地区皖北煤电集团总医院放疗科

出处《中国医药指南》 2014年第19期287-288,共2页 Guide of China Medicine

关键词紫杉醇顺铂同期放疗局部区域性食管癌临床效果

分类号 R735.1 [医药卫生—肿瘤]

引文网络
相关文献

参考文献5

1刘丽华,谢朝辉,张振才,刘金凤,王薇,刘秀春.紫杉醇每周给药同步调强放射治疗食管癌的效果观察[J].实用医技杂志,2012,19(1):7-8. 被引量：1
2邓霞,吴式琇,孙成超,谢聪颖,张萍.紫杉醇联合顺铂同步放化疗治疗术后食管癌52例[J].肿瘤学杂志,2009,15(7):641-644. 被引量：1
3万秋燕,张萍,邓霞,邹燕,吴式琇.紫杉醇与顺铂同步化疗联合放疗治疗老年食管癌33例分析[J].肿瘤学杂志,2010,16(1):25-29. 被引量：6
4Hiripi E,Jansen L,Gondos A. Survival of stomach and esoph-agus cancer patients in Germany in the early 21st century[J].ACTA ONCOLOGICA,2012,(07):3-4.
5Di Pietro M,Lao-Sirieix P,Boyle S. Evidence for a functional role of epigenetically regulated midcluster HOXB genes in the development of Barrett esophagus[J].Proceedings of the National Academy of Sciences(USA),2012,(23):41-42.

二级参考文献23

1黄镜,蔡锐刚,孟平均,张明娟,崔成旭,杨林,储大同,孙燕,王金万.紫杉醇联合顺铂治疗晚期食管鳞癌[J].中华肿瘤杂志,2004,26(12):753-755. 被引量：96
2常红霞,申仰之,王爱红.紫杉醇联合治疗中晚期上消化道癌的临床研究[J].中国药物与临床,2005,5(2):144-146. 被引量：2
3谢朝辉.周剂量紫杉醇同步后程加速超分割放疗治疗24例食管癌[J].肿瘤学杂志,2006,12(5):422-423. 被引量：9
4Holmes RS, Vaughan TL. Epidemiology and pathogenesis of esophageal cancer[J]. Semin Radiat Oncol, 2007, 17(1): 2-9.
5Cooper JS, Guo MD, Herskovic A, et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group [J]. JAMA, 1999, 281 (17):1623-1627.
6Servagi-Vernat S, Bosset M, Crehange G, et al. Feasibility of chemoradiotherapy for oesophageal cancer in elderly patients aged > or =75 years: a prospective, single-arm phase Ⅱ study[J]. Drugs Aging, 2009, 26(3):255-262.
7Anderson SE, Minsky BD, Bains M, et al. Combined modality chemoradiation in elderly oesophageal cancer patients[J], Br J Cancer, 2007, 96(12): 1823-1827.
8Minsky BD, Pajak TF, Ginsberg RJ, et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase Ⅲ trial of combined-modality therapy for esophageal cancer: highdose versus standard-dose radiation therapy[J]. J Clin Oncol, 2002, 20(5):1167-1174.
9Enzinger PC, Mayer RJ. Esophageal cancer [J]. N Engl J Med, 2003, 349(23):2241-2252.
10Gaspar LA, Winter K, Kocha WI, et al. A phase I/Ⅲ study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207): final report[J]. Cancer, 2000, 88(5):988-995.